ClassID:

92825

C07C235/14 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring

Recent Application in this class:
#1
20260055048
2026-02-26

PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION

#2
20240417369
2024-12-19

RXFP1 AGONISTS

#3
20240360075
2024-10-31

N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF

#4
20230150922
2023-05-18

Fluorinated Derivatives of Gabapentin and Methods of Use Thereof

#5
20220281804
2022-09-08

Cyclic diones as herbicidal compounds

#6
20220106281
2022-04-07

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#7
20210179573
2021-06-17

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#8
20210145771
2021-05-20

N-(3-(2-(4-CHLOROPHENOXY)ACETAMIDO)BICYCLO[1.1.1] PENTAN-1-YL)-2-CYCLOBUTANE-1- CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES

#9
20200270221
2020-08-27

Analgesic compounds

#10
20200087272
2020-03-19

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#11
20190375704
2019-12-12

Modulators of the eIF2alpha pathway

#12
20190256481
2019-08-22

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#13
20190256480
2019-08-22

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#14
20190240171
2019-08-08

Preventive and therapeutic approach for aberrant cell differentiation and ISR-associated diseases

#15
20190135772
2019-05-09

Modulators of the integrated stress pathway

#16
20180273500
2018-09-27

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#17
20180237405
2018-08-23

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#18
20170342020
2017-11-30

Modulators of the eIF2alpha pathway

#19
20160096800
2016-04-07

Modulators of the eIF2alpha pathway

#20
20160024251
2016-01-28

Thermoresponsive polyesters

#21
20160024044
2016-01-28

Inhibiting neurotransmitter reuptake

#22
20150252013
2015-09-10

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#23
20150065508
2015-03-05

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#24
20130237573
2013-09-12

4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists

#25
20130089611
2013-04-11

RASAGILINE CITRAMIDE

#26
20130045978
2013-02-21

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#27
20120271057
2012-10-25

Synthetic processes for the preparation of aminocyclohexyl ether compounds

#28
20120065408
2012-03-15

Synthetic processes for the preparation of aminocyclohexyl ether compounds

#29
20110218214
2011-09-08

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#30
20110021448
2011-01-27

Inhibitors for the soluble epoxide hydrolase

#31
20100267738
2010-10-21

Amide and amidine derivatives and uses thereof

#32
20100261920
2010-10-14

Amide compound and bacterial disease control agent for agricultural and horticultural use

#33
20100217014
2010-08-26

Synthetic processes for the preparation of aminocyclohexyl ether compounds

#34
20100158996
2010-06-24

ESTER COMPOUND AND MEDICAL USE THEREOF

#35
20100099682
2010-04-22

ACETYLENE DERIVATIVES

#36
20100022597
2010-01-28

2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors

#37
20090220451
2009-09-03

Cyclopropyl compounds and compositions for delivering active agents

#38
20090192198
2009-07-30

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

#39
20090131434
2009-05-21

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

#40
20090093664
2009-04-09

Functionalized carbon nanotubes, recovery of radionuclides and separation of actinides and lanthanides

#41
20080214673
2008-09-04

Acetylene derivatives

#42
20080177050
2008-07-24

Alpha, omega-difunctional aldaramides

#43
20070281954
2007-12-06

Cyclohexyl-1,4-diamine compounds

#44
20070117803
2007-05-24

Cyclohexyl-1,4-diamine compounds

#45
20070021427
2007-01-25

Tricyclic derivatives and their use

#46
20070015924
2007-01-18

Synthetic processes for the preparation of aminocyclohexyl ether compounds

#47
20060281773
2006-12-14

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#48
20060270609
2006-11-30

Inhibitors for the soluble epoxide hydrolase

#49
20060258886
2006-11-16

Alpha, omega-difunctional aldaramides

#50
20060178366
2006-08-10

Compounds for the treatment of inflammatory disorders

#51
20060111406
2006-05-25

Amide linker peroxisome proliferator activated receptor modulators

#52
20050075367
2005-04-07

Ester compound and medicinal use thereof